Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARK: Kuvan in PKU Children <4 Years
NCT01376908Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Jun 2011
- Primary completion
- Jul 2014
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 9
01
Overview
A Phase 3 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Jun 2011; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01376908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376908.